Ocular surface toxicities associated with modern anticancer therapies
R Boucher, O Haigh, E Barreau, S Champiat… - Survey of …, 2023 - Elsevier
Cancer treatments have recently shifted from broad-spectrum cytotoxic therapies to more
focused treatments, maximizing anti-cancerous activity while reducing toxicity to healthy …
focused treatments, maximizing anti-cancerous activity while reducing toxicity to healthy …
[HTML][HTML] MiRNA 24-3p-rich exosomes functionalized DEGMA-modified hyaluronic acid hydrogels for corneal epithelial healing
X Sun, W Song, L Teng, Y Huang, J Liu, Y Peng, X Lu… - Bioactive Materials, 2023 - Elsevier
The damage of corneal epithelium may lead to the formation of irreversible corneal opacities
and even blindness. The migration rate of corneal epithelial cells directly affects corneal …
and even blindness. The migration rate of corneal epithelial cells directly affects corneal …
Pan-cancer analysis of prognostic and immunological role of IL4I1 in human tumors: a bulk omics research and single cell sequencing validation
B Chen, Y Liu, Y He, C Shen - Discover Oncology, 2024 - Springer
Background Interleukin-4 inducible gene 1 (IL4I1) regulates tumor progression in numerous
tumor types. However, its correlation with immune infiltration and prognosis of patients in a …
tumor types. However, its correlation with immune infiltration and prognosis of patients in a …
Corneal melt associated with cancer immunotherapy
J Hsu, L Dixit, V Jhanji, S Ahmad - Cornea Open, 2023 - journals.lww.com
Purpose: The purpose of this study was to describe cases of corneal melt associated with
systemic cancer immunotherapy. Methods: This is a case series of 6 patients. Results …
systemic cancer immunotherapy. Methods: This is a case series of 6 patients. Results …
A case of corneal melting in a patient with HER2-positive breast cancer
D Peeters, M Vereecken, H Denys… - Case Reports in …, 2022 - karger.com
Trastuzumab is the cornerstone treatment for HER2-positive breast cancer. While ocular
side effects are more commonly described after the use of the antibody-drug conjugate ado …
side effects are more commonly described after the use of the antibody-drug conjugate ado …
[PDF][PDF] Immunologic-allergic corneal infiltrate in atopic patient undergoing multidrug topical treatment for POAG: Diagnostic and therapeutic management
M Troisi, S Troisi - Open J Clin Med Images, 2023 - researchgate.net
The authors present a case of ocular surface inflammation, Meibomian Gland Dysfunction
(MGD), and marginal corneal ulcers that occurred in atopic patient with multitherapy topical …
(MGD), and marginal corneal ulcers that occurred in atopic patient with multitherapy topical …